Search

ABSTRACT: Male reproductive tract disorders (MRTDs) are common in equids and may represent a significant proportion of the caseload of equine practitioners. Herein, we determined the frequency, clinico-pathological findings, and therapeutics of MRTDs in equids from a 9-year survey of the clinical records of a Veterinary Teaching Hospital in Midwestern Brazil. During this period, 87 affected equids presented 100 MRTDs distributed in 17 different diagnoses. Forty-three (49.4%) equids presented MRTDs affecting the glans penis or preputial skin fold. Testicles, scrotum, and spermatic cords disorders were diagnosed in 32 (36.8%) horses. Of the remaining 12 (13.8%) horses, six presented two different MRTDs on two distinct anatomical areas, and five animals exhibited the same disease, affecting two different anatomical locations. Only one horse presented three distinct MRTDs on two anatomical regions. Habronemiasis was the most frequent MRTD detected in 26% of the diagnoses, followed by miscellaneous wounds (14%), cryptorchidism (13%), inguinal hernia (13%), funiculitis (9%), paraphimosis (6%), squamous cell carcinoma (5%), urethrolithiasis (3%), preputial abscesses, and orchitis (2% each). Phimosis, ulcerative posthitis, epididymitis, hydrocele, papillomatosis, teratoma, and testicular torsion accounted for 1% each. Sixty-three (72.5%) equids received hospital discharge, 18 (20.6%) were humanely euthanized, and six (6.9%) died. This study detected the most relevant MRTDs that affected over 7.5% in a survey of 1,154 equids referred for hospital care. Our finding highlights that MRTDs may be debilitating and life-threatening conditions, and they can potentially impact the reproduction of equids in the region. This knowledge may support equine practitioners in elaborating proper sanitary and management protocols to prevent and reduce the incidence of most MRTDs recorded, improving equid production and welfare.

Summary: The present report describes a case of cutaneous papillomatosis related to equine papillomavirus type 2 (EcPV2) with concomitant cutaneous habronemiasis. A 2‐year‐old female Pura Raza Española horse was referred for a dermatological evaluation because of the onset of cutaneous multifocal, nodular lesions on the face characterised by a warty and partially ulcerated overlying epidermis. Multiple biopsies were taken from these lesions, and cutaneous viral papillomas with a concomitant severe focal eosinophilic dermatitis with intralesional Habronematidae nematode larvae were diagnosed. Immunohistochemistry revealed papillomaviral capsid protein L1 in the epidermal proliferative lesion, confirming the presence of a productive infection. Rt‐qPCR confirmed the presence of EcPV type 2. To the authors' knowledge, this is the first report of EcPV2‐related papillomas with concurrent habronemiasis. [ABSTRACT FROM AUTHOR]

Background: Equine cutaneous habronemiasis is common in the distal regions of the limbs. Organophosphates, applied systemically, one previously used treatment, which is highly effective, but currently in disuse, due to the risks of intoxication. Regional perfusion is a potential technique for distal limb wounds, since, in addition to being used in low doses, it prevents systemic circulation of the drug and possible intoxication, and has a lower treatment cost. The current work aimed to perform clinical, laboratory, and venography evaluations of the use of trichlorfon in regional intravenous perfusion, as a possible form of treatment for cutaneous habronemosis in the distal region of equine limbs. Materials, Methods & Results: Twelve equines were used, divided into 2 groups, with the left thoracic limb (LTL) being the test limb, and the right thoracic limb (RTL) the control limb. At moment zero (M0), distal radiography and venography were performed. The tourniquet was then loosened and after 5 min, at moment one (M1), the tourniquet was repositioned for 1.25 mg/kg (G1) and 5.5 mg/kg (G2) trichlorfon injections into the left thoracic limb, diluted in 20 mL of Ringer’s lactate solution, and 20 mL of Ringer’s lactate solution was applied to the right thoracic limb. The tourniquet was maintained for 30 min after infusion in both groups. At moment 2 (M2), 4 days later, blood tests, radiography, and venography were repeated. Every day between M0 and M2, physical examinations were performed, including measurement of the pastern, fetlock, and coronet band, and a lameness examination. There were no significant alterations in clinical parameters, behavior, and appetite. In the blood cell count, there was an increase in leukocytes on D4 in G2, although remaining within the reference values for the species. The biochemical tests showed no alterations. There were no changes in the circumferences evaluated and 4 equines from G2 presented lameness in the LTL and 1 in the RTL. In the venograms, 1 G2 animal was noticed to be hypoperfused in all LTL plexuses. Discussion: The use of trichlorfon in regional perfusion at a dose of 1.25 mg/kg demonstrated safety, with no clinical, laboratory, and lameness changes in any of the animals. At the highest dose (5.5 mg/kg), individual reactions were observed, such as different degrees of lameness, swelling, and heat in foot. Serial venographies document the response to treatment used, it was decided to perform the second venography 4 days after the trichlorfon perfusion and the first initial venography evaluation, following the recommendations for the repetition time of the examination and evaluation of the use of the drug. The evaluation of radiographic images of venography, in a grading system created considering the range of contrast in 5 regions by the 3 examiners experienced in podiatry and the analysis of radiographic images of limbs of equines, without having participated in the previous procedures was important for the reliability of the assessment. The areas of hypoperfusion observed in the venography were not related to trichlorfon perfusion. It is essential that the application of trichlorfon be performed correctly, intravenously, to avoid reactions such as necrosis, pain, edema, erythema, lameness, and even more severe inflammatory reactions, such as phlegmon and thrombophlebitis. Although a small number of animals were used in this study, trichlorfon regional perfusion of equine limbs, at a dose of 1.25 mg/kg may be a technique appears to be inert to hoof vascularization. [ABSTRACT FROM AUTHOR]